# Stateline Angels

> Stateline Angels is a VC fund in Rockford backing Health Care and Biotechnology. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Rockford, United States
- Total investments: 5
- Last investment: Sep 2025
- Lead investor: 20%
- Last updated: Aug 2026
- Website: http://www.statelineangels.com

Stateline Angels is an angel investor organization that provides investment capital to start-up and early stage companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 80% |
| Biotechnology | 4 | 80% |
| Medical Device | 3 | 60% |
| Medical | 1 | 20% |
| Hospitality | 1 | 20% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Funding Round | 2 | 40% |
| Convertible Note | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Madison Scientific | Madison Scientific develops an integrated management solution aimed at optimizing treatment for hydrocephalus patients. The company focuses on creating novel neurological devices and is involved in the biotechnology and medical equipment manufacturing industries. Their solutions are designed to improve patient outcomes through innovative technologyand comprehensive treatment plans. | $3M | Seed | Sep 08, 2025 |  |
| Novilytic | Monitoring the quality of lifesaving medicines is Novilytic’s mission. We accomplish this via the disruptive use of nanotechnology and cutting-edge science designed for Process R&D and pharmaceutical manufacturing.The Proteometer (Proteoform Meter) is a technology for drug development companies that can provide near-real-time warnings onmolecular structure changes. Like a canary in an old coal mine, the Proteometer serves as our “Canary in the Fermentor.” This technology will be sold in the form of kits that allow customers to convert their LCs into a Proteometer in a short period of time. Training and service all remain the same, including one’s own software, thus ensuring ease of use and speed of adoption. Commercialization efforts are underway as the organization is preparing for an early 2023 product launch. --Novilytic is backed by more than 10 patents (and two pending), partnerships with multiple analytical instrument companies, 2 pharmaceutical consortiums, and analytical science universities.Our talented team includes 5 Ph.D. chemists and engineers who have helped us secure significant patents and other IP. | $1.8M | Seed | May 03, 2022 |  |
| NovaScan | NovaScan provides diagnostic products that apply bioelectrical impedance to assess tissue characteristics relevant to cancer detection. Its MarginScan device performs ex vivo and in vivo margin evaluation by generating immediate electrical measurements during clinical procedures. The nsCanary tool examines biopsy cores directly after sampling toindicate whether malignant tissue is present. NovaScan also uses machine-learning models to interpret impedance signatures and distinguish cancerous from non-cancerous tissue. These products are designed to support clinical decision-making through rapid, instrument-based analysis. | $3M | Convertible Note | Jan 22, 2021 |  |
| NorthStar Medical Radioisotopes | NorthStar Medical Radioisotopes LLC (northstarnm.com) was founded in 2006 to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negativelyimpacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market. | $5.2M |  | Sep 05, 2012 |  |
| Ratio | Ratio, Inc., a medical device company, develops and produces drug delivery pumps. It offers disposable drug delivery pump, a non-electronic and hydrogel-based drug delivery technology that delivers large molecule drugs and various biologics into the skin via microneedles. The company also provides painless and active transdermal products. Ratio,Inc. was founded in 2005 and is based in Monona, Wisconsin.. | $221.5K |  | Jan 01, 2012 |  |

5 of 5 investments shown.

## Co-investors
- [BioPacific Investors](https://shizune.co/investors/profile/biopacific-investors) — VC Fund, 1 deal together
- [Central Illinois Angels](https://shizune.co/investors/profile/central-illinois-angels) — VC Fund, 1 deal together
- [Elevate Ventures](https://shizune.co/investors/profile/elevate-ventures) — VC Fund, 1 deal together
- [Endeavor Health](https://shizune.co/investors/profile/endeavor-health) — VC Fund, 1 deal together
- [Green Park & Golf Ventures](https://shizune.co/investors/profile/green-park-golf-ventures) — VC Fund, 1 deal together
- [Harvard Business School Angels Chicago](https://shizune.co/investors/profile/harvard-business-school-angels-chicago) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Stateline Angels invest in?

Stateline Angels invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Stateline Angels last invest?

The most recent investment recorded for Stateline Angels closed in Sep 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co